Finanzwire Finanzwire
Basculer en Français
9629 Companies
191456 Keywords
122915 Articles
102031 Press releases
Headlines Articles Press releases Morphogenesis Inc. Remove
  1. Home
  2. Companies
  3. Morphogenesis Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/25/2024 at 15:05, 1 year 8 months ago

    TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

    Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
  • PRESS RELEASE

    published on 04/25/2024 at 15:00, 1 year 8 months ago

    TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

    TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs
    Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 12/14/2023 at 16:00, 2 years ago

    Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview

    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 11/08/2023 at 15:00, 2 years 2 months ago

    Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

    Logo of Morphogenesis Inc.
Accesswire
  • Published on 01/10/2026 at 05:10, 1 day 7 hours ago

    Sekur Private Data Ltd. Announces Non-Brokered Private Placement

  • Published on 01/10/2026 at 00:45, 1 day 12 hours ago

    Digi Power X Announces Entry into Settlement Agreement

  • Published on 01/09/2026 at 23:30, 1 day 13 hours ago

    Sun Peak Metals Grants Stock Options

  • Published on 01/09/2026 at 23:30, 1 day 13 hours ago

    Matador Technologies Announces Grant of Restricted Share Units to Management Team

  • Published on 01/09/2026 at 23:10, 1 day 13 hours ago

    Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE
EQS Group
  • Published on 01/10/2026 at 21:25, 15 hours 43 minutes ago

    CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh

  • Published on 01/10/2026 at 13:05, 1 day ago

    SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation

  • Published on 01/09/2026 at 21:55, 1 day 15 hours ago

    Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

  • Published on 01/09/2026 at 18:36, 1 day 18 hours ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 01/09/2026 at 18:19, 1 day 18 hours ago

    EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG

View all EQS
Les Echos
  • Published on 01/09/2026 at 18:30, 1 day 18 hours ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 1 day 19 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 1 day 19 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 1 day 19 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

  • Published on 01/08/2026 at 21:00, 2 days 16 hours ago

    Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy